Welcome to the CAR-TCR Summit Europe!
Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR and TCR therapies better, and faster.
Take advantage of cutting-edge innovation from global biopharma leaders in cell armouring, combination approaches and multiplexing gene engineering to improve cell durability and trafficking across allogeneic and solid tumour indications, and leave understanding the technical strategies to build automated, closed-system manufacturing processes to ensure vein to vein time is less than a week.
Promising data-driven case studies outlining next generation product design, clinical trial set-up and manufacturing processes, this meeting is your go-to to comprehensively assess the emerging improvements of CAR and TCR based therapies.
View the 2023 Agenda Now:
View the speaker faculty, full agenda details, partners and partnership opportunities, and how to access the best possible rates - all in one handy guide.
2023 Speakers Include:
President & Chief Executive Officer
Chief Executive Officer
Co-Founder & Chief Scientific Officer
“The CAR-TCR Summit Europe is always a highlight for me. It is the meeting that really takes a long hard look at the future of our space and brings the worlds CAR/TCR leaders together in one place to learn, educate and collaborate.”
Sven Kili, Chief Executive Officer, Antion Biosciences
Who's Attending in 2023:
Team Discounts Available:
3 Passes - 10% Discount
4 Passes - 15% Discount
5+ Passes - 20% Discount
“As the field matures and diversifies from technology base standpoint, I am very excited about this summit as it showcases next generation treatment modalities.”
Adrian Bot, Chief Scientific Officer & Executive Vice President of R&D, Capstan Therapeutics